This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Craig Duvall, Ph.D.
Cornelius Vanderbilt Professor of Biomedical Engineering at Vanderbilt University


Dr. Craig L. Duvall is Cornelius Vanderbilt Professor of Biomedical Engineering at Vanderbilt University. He completed his Ph.D. in BME at Georgia Tech and Emory University in 2007 under the guidance of Robert Guldberg, Ph.D. and W. Robert Taylor, M.D., Ph.D. His postdoc was completed in Bioengineering in the labs of Patrick Stayton and Allan Hoffman at the University of Washington through support from an NIH NRSA-funded postdoctoral fellowship. Based on these foundations, the Duvall Advanced Therapeutics Laboratory (ATL) was launched in the Vanderbilt Biomedical Engineering Department in 2010, and Dr. Duvall was promoted to Associate Professor in 2016, Professor in 2019, and Cornelius Vanderbilt Professor in 2019. Dr. Duvall has won awards such as the PECASE, NSF CAREER Award, AHA Scientist Development Grant, Society for Biomaterials Young Investigator Award, BMES Cellular and Molecular Bioengineering Young Innovator Award, AIMBE Fellow, Controlled Release Society Gene Delivery and Gene Editing Focus Group Young Investigator Award, and standing membership on the Gene and Drug Delivery NIH Study Section. The ATL is funded by grants from the National Institutes of Health, Department of Defense, and National Science Foundation.

Agenda Sessions

  • Precision Polymer Architectures and Molecular Conjugates to Enable Nucleic Acid and Peptide Therapeutics Against Undruggable Targets